FIRST SUPPLEMENTAL INDENTUREFirst Supplemental Indenture • October 24th, 2013 • Supernus Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 24th, 2013 Company Industry JurisdictionTHIS SUPPLEMENTAL INDENTURE, dated as of October 24, 2013, to the Indenture (as defined below), is hereby entered into by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Issuer”), and U.S. Bank National Association, a national banking association (the “Trustee”) (this “Supplemental Indenture”).